There are millions of people who carry anti-cholesterol pills in their pockets. Official records state that eight million people consume statins to lower their risk of heart and circulatory diseases. Now, new research suggests that they do more than just benefiting your heart, they also mitigate the risk of cancer. Recently, a study was conducted on blood cancer patients who were taking these pills at the start of their treatment. It was found that 61% per cent of them had a lower risk of cancer as compared to those not taking statins.Here's The Research ExplainedThe research involved 1,467 patients with chronic lymphocytic leukaemia (a type of blood and bone marrow cancer) or small lymphocytic lymphoma, with an average age of 65. Patients were enrolled in one of four trials looking at the effects of a targeted cancer drug called ibrutinib. The dose of statin was adjusted according to varied factors like age, gender, among others. Regardless of those factors, patients taking statins were found to have a 61% lower risk of dying from their cancer, a 38% lower risk of dying from any cause, and a 26% lower risk of their disease progressing. But What Is Statin?Statins are a class of medications primarily used to lower cholesterol levels in the blood. They work by blocking the enzyme HMG-Coa reductase, which is crucial for the liver's production of cholesterol. By reducing cholesterol production, statins help lower the risk of heart disease and stroke.Cancer Is The Leading Cause Of Death In The WorldCancer is the leading cause of death across the world. According to the World Health Organisation (WHO), it killed 10 Million people in 2020, with breast and lung cancer. and which can then invade adjoining parts of the body and spread to other organs; the latter process is referred to as metastasis. Widespread metastases are the primary cause of death from cancer. The study was led by Dr Ahmad Abuhelwa, an assistant professor of pharmacy practice and pharmacotherapeutics at the University of Sharjah in the United Arab Emirates. Talking about the research, he said, "These findings don’t allow us to say for certain that statins directly improve cancer outcomes."